(Q40287632)

English

Rapid and massive expansion of cord blood-derived cytokine-induced killer cells: an innovative proposal for the treatment of leukemia relapse after cord blood transplantation

scientific article published on 18 September 2006

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Rapid and massive expansion of cord blood-derived cytokine-induced killer cells: an innovative proposal for the treatment of leukemia relapse after cord blood transplantation (English)

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

author name string

Introna M

1

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Franceschetti M

2

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Ciocca A

3

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Borleri G

4

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Conti E

5

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Golay J

6

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Rambaldi A

7

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

language of work or name

0 references

publication date

18 September 2006

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Bone Marrow Transplantation

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

38

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

9

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

621-627

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Umbilical cord blood transplantation: a new alternative option.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705503

21 January 2018

Cord blood immunology and stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705503

21 January 2018

Outcomes after transplantation of cord blood or bone marrow from unrelated donors in adults with leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705503

21 January 2018

Expansion of cytotoxic CD3+ CD56+ cells from peripheral blood progenitor cells of patients undergoing autologous hematopoietic cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705503

21 January 2018

Use of a SCID mouse/human lymphoma model to evaluate cytokine-induced killer cells with potent antitumor cell activity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705503

21 January 2018

The antileukemia effect of HLA-matched NK and NK-T cells in chronic myelogenous leukemia involves NKG2D-target-cell interactions

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705503

21 January 2018

Engineering hematopoietic grafts: purified allogeneic hematopoietic stem cells plus expanded CD8+ NK-T cells in the treatment of lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705503

21 January 2018

Revealing lymphoma growth and the efficacy of immune cell therapies using in vivo bioluminescence imaging

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705503

21 January 2018

Visualizing the kinetics of tumor-cell clearance in living animals

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705503

21 January 2018

A phase I trial of autologous cytokine-induced killer cells for the treatment of relapsed Hodgkin disease and non-Hodgkin lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705503

21 January 2018

Antitumor activities of human autologous cytokine-induced killer (CIK) cells against hepatocellular carcinoma cells in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705503

21 January 2018

IL-2-activated cord blood mononuclear cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705503

21 January 2018

Ex vivo expanded umbilical cord blood T cells maintain naive phenotype and TCR diversity.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705503

21 January 2018

Novel adopted immunotherapy for mixed chimerism after unrelated cord blood transplantation in Omenn syndrome.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705503

21 January 2018

Role of NKG2D signaling in the cytotoxicity of activated and expanded CD8+ T cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705503

21 January 2018

HSV-TK gene transfer into donor lymphocytes for control of allogeneic graft-versus-leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705503

21 January 2018

Administration of herpes simplex-thymidine kinase-expressing donor T cells with a T-cell-depleted allogeneic marrow graft

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705503

21 January 2018

Herpes simplex thymidine kinase gene-transduced donor lymphocyte infusions

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705503

21 January 2018

Initial depletion of regulatory T cells: the missing solution to preserve the immune functions of T lymphocytes designed for cell therapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705503

21 January 2018

Transplants of Umbilical-Cord Blood or Bone Marrow from Unrelated Donors in Adults with Acute Leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705503

21 January 2018

Cord-blood transplantation in patients with leukemia--a real alternative for adults

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705503

7 January 2021

based on heuristic

inferred from DOI database lookup

Expansion of cytolytic CD8(+) natural killer T cells with limited capacity for graft-versus-host disease induction due to interferon gamma production

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705503

7 January 2021

based on heuristic

inferred from DOI database lookup

Generation of cytokine-induced killer cells from leukaemic samples with in vitro cytotoxicity against autologous and allogeneic leukaemic blasts

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705503

7 January 2021

based on heuristic

inferred from DOI database lookup

Autologous cytokine-induced killer cell therapy in clinical trial phase I is safe in patients with primary hepatocellular carcinoma.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705503

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/SJ.BMT.1705503

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40287632&oldid=2203570936"